FIGO at WHA71
During the World Health Assembly 2018, FIGO took a delegation of our members from Bolivia, Finland, India, Kenya, United Kingdom and the United States.
Together we delivered two highly successful panel sessions:
Addressing Gynecological Oncology - Early Detection and Prevention
Is integral if we are to progress towards reducing premature mortality attributed to cancer (SDG 3.4).
Join FIGO and our high profile experts at our Official Side Event at the 71st World Health Assembly.
When: Wednesday 23 May 2018, 6.00 - 6.50pm
Where: Meeting Room IX, 3rd Floor, WHO, Geneva
Master of Ceremony: Professor Seija Grenman – FIGO Vice President, Finland.
FIGO is a professional organisation that brings together obstetrical and gynecological associations from all over the world. Our vision is that women of the world achieve the highest possible standards of physical, mental, reproductive and sexual health and wellbeing throughout their lives.
• Overview on gynecological oncology, epidemiology and global prevalence Professor CN Purandare, FIGO President, India
• Elimination of cervical cancer in LMICs - How FIGO can contribute Professor Neerja Bhatla, FIGO Chairperson, Gynecologic Oncology Committee, India
• African perspective on cervical cancer, diagnosis and treatment – reducing mortality Dr Anne Kihara, FIGO President-Elect, African Federation of Obstetrics and Gynecology, Kenya
• WHO’s global role on gynecological oncology and the SDGs Dr Cherian Varghese, Coordinator, Management of Non-communicable Diseases, WHO
• Assessment and management of breast disease in low-resource settings Dr Barbara Levy, Vice President Health Policy, ACOG, USA
Hear updates on the latest knowledge on the FIGO Cancer Staging App, and learn about the implications to structural healthcare systems to reduce mortality and morbidity rates that will address SDG 3.
Pregnancy and NCDs side event
Join the global voice for women's health, FIGO and high profile expert panelists to discuss the essential link between women’s health and addressing and preventing NCDs including the unique opportunity which pregnancy gives for prevention and management of NCDs for mother and offspring.
When: Friday 25th May, 8.00 - 9.30am (breakfast provided)
Where: The Ballroom B-C, Intercontinental Geneva
Why you should attend: The global community is beginning to understand the enormity of the health and economic challenges that NCDs present.
It’s estimated that by 2030, NCDs are projected to claim 52 million lives annually, almost 80% in low- or low/middle-income countries.
Undernutrition and obesity; hypertension; hyperglycaemia etc are commonly associated with pregnancy and can lead to poor pregnancy outcomes. To improve both the short term outcomes and long-term population health, NCDs must be addressed simultaneously alongside maternal health.
Professor CN Purandare, FIGO President, India
Professor Moshe Hod, Chair of FIGO Pregnancy & NCD Committee, Israel
Katie Dain, Chief Executive, NCD Alliance, United Kingdom
Dr Doris Chou, WHO
Dr Anne Kihara, President Elect, AFOG, Kenya